Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 11:47:20 UTC |
---|
Update Date | 2021-09-26 23:06:32 UTC |
---|
HMDB ID | HMDB0253371 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Idalopirdine |
---|
Description | Idalopirdine belongs to the class of organic compounds known as tryptamines and derivatives. Tryptamines and derivatives are compounds containing the tryptamine backbone, which is structurally characterized by an indole ring substituted at the 3-position by an ethanamine. Idalopirdine is a very strong basic compound (based on its pKa). As of October 2013 it is in phase III clinical trials. Idalopirdine (INN) (code names Lu AE58054,) is a potent and selective 5-HT6 receptor antagonist under development by Lundbeck as an augmentation therapy for the treatment of cognitive deficits associated with Alzheimer's disease and schizophrenia. Two further phase III trials failed too, the company confirmed in early 2017. A phase III trial of two different daily doses of Lu AE58054 on top of 10 mg of donepezil for mild-to-moderate Alzheimer's failed to meet its primary endpoint with either dose. This compound has been identified in human blood as reported by (PMID: 31557052 ). Idalopirdine is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Idalopirdine is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | FC(F)C(F)(F)COC1=CC=CC(CNCCC2=CNC3=CC(F)=CC=C23)=C1 InChI=1S/C20H19F5N2O/c21-15-4-5-17-14(11-27-18(17)9-15)6-7-26-10-13-2-1-3-16(8-13)28-12-20(24,25)19(22)23/h1-5,8-9,11,19,26-27H,6-7,10,12H2 |
---|
Synonyms | Value | Source |
---|
LU-ae58054 | ChEMBL | LU ae58054 | ChEMBL | (2-(6-fluoro-1H-indol-3-yl)-Ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine | MeSH |
|
---|
Chemical Formula | C20H19F5N2O |
---|
Average Molecular Weight | 398.377 |
---|
Monoisotopic Molecular Weight | 398.141754055 |
---|
IUPAC Name | [2-(6-fluoro-1H-indol-3-yl)ethyl]({[3-(2,2,3,3-tetrafluoropropoxy)phenyl]methyl})amine |
---|
Traditional Name | [2-(6-fluoro-1H-indol-3-yl)ethyl]({[3-(2,2,3,3-tetrafluoropropoxy)phenyl]methyl})amine |
---|
CAS Registry Number | Not Available |
---|
SMILES | FC(F)C(F)(F)COC1=CC=CC(CNCCC2=CNC3=CC(F)=CC=C23)=C1 |
---|
InChI Identifier | InChI=1S/C20H19F5N2O/c21-15-4-5-17-14(11-27-18(17)9-15)6-7-26-10-13-2-1-3-16(8-13)28-12-20(24,25)19(22)23/h1-5,8-9,11,19,26-27H,6-7,10,12H2 |
---|
InChI Key | YBAWYTYNMZWMMJ-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as tryptamines and derivatives. Tryptamines and derivatives are compounds containing the tryptamine backbone, which is structurally characterized by an indole ring substituted at the 3-position by an ethanamine. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Indoles and derivatives |
---|
Sub Class | Tryptamines and derivatives |
---|
Direct Parent | Tryptamines and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Tryptamine
- 3-alkylindole
- Indole
- Phenoxy compound
- Benzylamine
- Phenol ether
- Phenylmethylamine
- Alkyl aryl ether
- Aralkylamine
- Aryl fluoride
- Aryl halide
- Monocyclic benzene moiety
- Substituted pyrrole
- Benzenoid
- Heteroaromatic compound
- Pyrrole
- Secondary amine
- Azacycle
- Secondary aliphatic amine
- Ether
- Amine
- Hydrocarbon derivative
- Organohalogen compound
- Organic oxygen compound
- Alkyl halide
- Alkyl fluoride
- Organic nitrogen compound
- Organofluoride
- Organonitrogen compound
- Organooxygen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Idalopirdine,1TMS,isomer #1 | C[Si](C)(C)N(CCC1=C[NH]C2=CC(F)=CC=C12)CC1=CC=CC(OCC(F)(F)C(F)F)=C1 | 2775.4 | Semi standard non polar | 33892256 | Idalopirdine,1TMS,isomer #1 | C[Si](C)(C)N(CCC1=C[NH]C2=CC(F)=CC=C12)CC1=CC=CC(OCC(F)(F)C(F)F)=C1 | 2704.3 | Standard non polar | 33892256 | Idalopirdine,1TMS,isomer #1 | C[Si](C)(C)N(CCC1=C[NH]C2=CC(F)=CC=C12)CC1=CC=CC(OCC(F)(F)C(F)F)=C1 | 2840.5 | Standard polar | 33892256 | Idalopirdine,1TMS,isomer #2 | C[Si](C)(C)N1C=C(CCNCC2=CC=CC(OCC(F)(F)C(F)F)=C2)C2=CC=C(F)C=C21 | 2707.1 | Semi standard non polar | 33892256 | Idalopirdine,1TMS,isomer #2 | C[Si](C)(C)N1C=C(CCNCC2=CC=CC(OCC(F)(F)C(F)F)=C2)C2=CC=C(F)C=C21 | 2648.5 | Standard non polar | 33892256 | Idalopirdine,1TMS,isomer #2 | C[Si](C)(C)N1C=C(CCNCC2=CC=CC(OCC(F)(F)C(F)F)=C2)C2=CC=C(F)C=C21 | 2799.7 | Standard polar | 33892256 | Idalopirdine,2TMS,isomer #1 | C[Si](C)(C)N(CCC1=CN([Si](C)(C)C)C2=CC(F)=CC=C12)CC1=CC=CC(OCC(F)(F)C(F)F)=C1 | 2826.8 | Semi standard non polar | 33892256 | Idalopirdine,2TMS,isomer #1 | C[Si](C)(C)N(CCC1=CN([Si](C)(C)C)C2=CC(F)=CC=C12)CC1=CC=CC(OCC(F)(F)C(F)F)=C1 | 2708.3 | Standard non polar | 33892256 | Idalopirdine,2TMS,isomer #1 | C[Si](C)(C)N(CCC1=CN([Si](C)(C)C)C2=CC(F)=CC=C12)CC1=CC=CC(OCC(F)(F)C(F)F)=C1 | 2750.8 | Standard polar | 33892256 | Idalopirdine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(CCC1=C[NH]C2=CC(F)=CC=C12)CC1=CC=CC(OCC(F)(F)C(F)F)=C1 | 3014.5 | Semi standard non polar | 33892256 | Idalopirdine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(CCC1=C[NH]C2=CC(F)=CC=C12)CC1=CC=CC(OCC(F)(F)C(F)F)=C1 | 2892.1 | Standard non polar | 33892256 | Idalopirdine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(CCC1=C[NH]C2=CC(F)=CC=C12)CC1=CC=CC(OCC(F)(F)C(F)F)=C1 | 2918.7 | Standard polar | 33892256 | Idalopirdine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C=C(CCNCC2=CC=CC(OCC(F)(F)C(F)F)=C2)C2=CC=C(F)C=C21 | 2888.5 | Semi standard non polar | 33892256 | Idalopirdine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C=C(CCNCC2=CC=CC(OCC(F)(F)C(F)F)=C2)C2=CC=C(F)C=C21 | 2827.9 | Standard non polar | 33892256 | Idalopirdine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C=C(CCNCC2=CC=CC(OCC(F)(F)C(F)F)=C2)C2=CC=C(F)C=C21 | 2853.5 | Standard polar | 33892256 | Idalopirdine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(CCC1=CN([Si](C)(C)C(C)(C)C)C2=CC(F)=CC=C12)CC1=CC=CC(OCC(F)(F)C(F)F)=C1 | 3248.9 | Semi standard non polar | 33892256 | Idalopirdine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(CCC1=CN([Si](C)(C)C(C)(C)C)C2=CC(F)=CC=C12)CC1=CC=CC(OCC(F)(F)C(F)F)=C1 | 3045.1 | Standard non polar | 33892256 | Idalopirdine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(CCC1=CN([Si](C)(C)C(C)(C)C)C2=CC(F)=CC=C12)CC1=CC=CC(OCC(F)(F)C(F)F)=C1 | 2902.3 | Standard polar | 33892256 |
| Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Idalopirdine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0udj-6793000000-9e6083205d41a8dbd6f6 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Idalopirdine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Idalopirdine 10V, Positive-QTOF | splash10-0f6t-0619000000-26029a45a2a379d8d6fe | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Idalopirdine 20V, Positive-QTOF | splash10-03di-0934000000-a91c22799adfe23b1305 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Idalopirdine 40V, Positive-QTOF | splash10-0udi-0900000000-89cb12b5290b6a6895a6 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Idalopirdine 10V, Negative-QTOF | splash10-0002-0192000000-829486a501167862dfd8 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Idalopirdine 20V, Negative-QTOF | splash10-002b-0159000000-af25b8526ec58fe48a75 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Idalopirdine 40V, Negative-QTOF | splash10-0fai-1930000000-e3d8e2e22ae4df584dbf | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Idalopirdine 10V, Positive-QTOF | splash10-0002-0109000000-06097e1b9d156c8a25c7 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Idalopirdine 20V, Positive-QTOF | splash10-0gvk-0967000000-f2236ef10ea8bf84b768 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Idalopirdine 40V, Positive-QTOF | splash10-03dm-1900000000-f70cb45c333c5edc14fe | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Idalopirdine 10V, Negative-QTOF | splash10-0002-0009000000-b8db6b86e0b43dfba28a | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Idalopirdine 20V, Negative-QTOF | splash10-001i-0392000000-de4229216b4ef8454b7b | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Idalopirdine 40V, Negative-QTOF | splash10-00di-0900000000-a21135b9bfd9f790ebcc | 2021-10-12 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | Not Available |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected but not Quantified | Not Quantified | Not Specified | Not Specified | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB11957 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | Not Available |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Idalopirdine |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 21071390 |
---|
PDB ID | Not Available |
---|
ChEBI ID | Not Available |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]
|
---|